Farallon Capital Management LLC Assembly Biosciences, Inc. Transaction History

Farallon Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$17.7 - $24.93 $4.43 Million - $6.23 Million	-250,000 Reduced 71.43%	100,000 $1.97 Million
Q4 2018 Feb 14, 2019	BUY	$19.05 - $36.45 $952,500 - $1.82 Million	50,000 Added 16.67%	350,000 $7.92 Million
Q3 2018 Nov 14, 2018	BUY	$34.41 - $44.23 $10.3 Million - $13.3 Million	300,000 New	300,000 $11.1 Million
Q1 2018 May 15, 2018	SELL	$41.7 - $64.16 $10.4 Million - $16 Million	-250,000 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$28.58 - $49.91 $7.15 Million - $12.5 Million	250,000	250,000 $11.3 Million

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $822M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Farallon Capital Management LLC with notifications on news.